doi: 10.1111/j.1537-2995.2006.00842.x.
The National Marrow Donor Program with emphasis on the early years
Affiliations
- PMID: 16836575
- DOI: 10.1111/j.1537-2995.2006.00842.x
Item in Clipboard
The National Marrow Donor Program with emphasis on the early years
Transfusion.
2006 Jul.
No abstract available
Comment in
-
The National Marrow Donor Program in 2006: constants and challenges.Transfusion. 2006 Jul;46(7):1080-4. doi: 10.1111/j.1537-2995.2006.00889.x. Transfusion. 2006. PMID: 16836552 No abstract available.
-
The National Marrow Donor Program with emphasis on the early years.Transfusion. 2007 Jun;47(6):1101-2; author reply 1102. doi: 10.1111/j.1537-2995.2007.01261.x. Transfusion. 2007. PMID: 17524105 No abstract available.
Similar articles
-
The National Marrow Donor Program with emphasis on the early years.Transfusion. 2007 Jun;47(6):1101-2; author reply 1102. doi: 10.1111/j.1537-2995.2007.01261.x. Transfusion. 2007. PMID: 17524105 No abstract available.
-
The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation.Biol Blood Marrow Transplant. 2008 Sep;14(9 Suppl):2-7. doi: 10.1016/j.bbmt.2008.05.017. Biol Blood Marrow Transplant. 2008. PMID: 18721774
-
Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry.Biol Blood Marrow Transplant. 2008 Sep;14(9 Suppl):37-44. doi: 10.1016/j.bbmt.2008.05.001. Epub 2008 Jun 20. Biol Blood Marrow Transplant. 2008. PMID: 18721779 Review. No abstract available.
-
The National Marrow Donor Program: improving access to hematopoietic stem cell transplantation.Clin Transpl. 1999:121-7. Clin Transpl. 1999. PMID: 11038630
-
National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants.Biol Blood Marrow Transplant. 2008 Sep;14(9 Suppl):45-53. doi: 10.1016/j.bbmt.2008.06.014. Biol Blood Marrow Transplant. 2008. PMID: 18721780 Review. No abstract available.
Cited by
-
Targeting T Cell Bioenergetics by Modulating P-Glycoprotein Selectively Depletes Alloreactive T Cells To Prevent Graft-versus-Host Disease.J Immunol. 2016 Sep 1;197(5):1631-41. doi: 10.4049/jimmunol.1402445. Epub 2016 Jul 25. J Immunol. 2016. PMID: 27456485 Free PMC article.
-
Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer.Nat Rev Cancer. 2010 Mar;10(3):213-21. doi: 10.1038/nrc2804. Epub 2010 Feb 19. Nat Rev Cancer. 2010. PMID: 20168320 Review.
-
Safeguarding the long-term health of hematopoietic stem cell donors: a continuous and evolving process to maintain donor safety and trust.Expert Rev Hematol. 2012 Feb;5(1):1-3. doi: 10.1586/ehm.11.78. Expert Rev Hematol. 2012. PMID: 22272697 Free PMC article. No abstract available.
-
The HLA system: genetics, immunology, clinical testing, and clinical implications.Yonsei Med J. 2007 Feb 28;48(1):11-23. doi: 10.3349/ymj.2007.48.1.11. Yonsei Med J. 2007. PMID: 17326240 Free PMC article. Review.
-
Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant. 2019 Aug;25(8):1666-1673. doi: 10.1016/j.bbmt.2019.04.008. Epub 2019 Apr 12. Biol Blood Marrow Transplant. 2019. PMID: 30986499 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
